Healthcare | June 16, 2022
EPR-Technologies announces new approach to emergency care when CPR fails
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The new program includes upstream and downstream process development and large-scale GMP production.
The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management
Alopecia areata usually presents as a few small bald patches in the head
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Tislelizumab is now approved in nine indications in China
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
Subscribe To Our Newsletter & Stay Updated
